Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 29Other hematologic neoplasm 2Other 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Central Nervous System Neoplasms 20Brain Neoplasms 12Medulloblastoma 8Meningeal Carcinomatosis 6Rhabdoid Tumor 5Lymphoma 5Choroid Plexus Neoplasms 5Astrocytoma 5Neuroblastoma 4Ependymoma 4Breast Neoplasms 4Sarcoma 3Oligodendroglioma 3Lymphoma, Non-Hodgkin 2Gliosarcoma 2Glioblastoma 2Waldenstrom Macroglobulinemia 1Spinal Cord Neoplasms 1Sezary Syndrome 1Retinoblastoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Ototoxicity 1Osteosarcoma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1

Interventions

Cyclophosphamide 10Temozolomide 8X-Rays 7Specimen Handling 7Irinotecan 7Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Filgrastim 6Carboplatin 5Biopsy 5fludarabine 4Nuclear Medicine Department, Hospital 4olaparib 3fludarabine phosphate 3etoposide phosphate 3dinutuximab 3Zoledronic Acid 3Oxaliplatin 3Nivolumab 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Gemcitabine 3Etoposide 3Docetaxel 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2lorukafusp alfa 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Methotrexate × CNS × Clear all
NCT00513981 2013-06-26

High-Dose Methotrexate in Treating Young Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
CNSSarcoma

Familial ependymoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡